Secondary Cutaneous Myeloid Sarcoma Treated with Nanoliposomal Encapsulation of Daunorubicin and Cytarabine

Cutaneous myeloid sarcoma is a rare malignancy and most often arises in the setting of acute myeloid leukemia. Here, we present the unique case of a patient who developed secondary cutaneous myeloid sarcoma after developing myelodysplastic syndrome from breast cancer treatment. We describe complete resolution of her lesions after treatment with a nanoliposomal dual encapsulation of daunorubicin and cytarabine and to our knowledge the first known treatment of a patient with cutaneous myeloid sarcoma with this regimen.